nyaditum resae
Cell therapyexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT02076139)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nyaditum resae
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03851159 | N/A | Apr 16, 2019 | Badalona Hospital Germans Trias i Pujol, Stellenbosch University |
| NCT02897180 | Phase 2/Phase 3 (Phase 3) | Mar 10, 2017 | Badalona Hospital Germans Trias i Pujol, National Center for Tuberculosis and Lung Diseases, Georgia |
| NCT02581579 | N/A | Nov 1, 2015 | Manresana de Micobacteriologia, SL |
| NCT02076139 | N/A | Mar 1, 2014 | Badalona Hospital Germans Trias i Pujol, Manresana de Micobacteriologia, SL |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Badalona Hospital Germans Trias i Pujol | Academic/Hospital | 3 | 1 | 2 | 2014 |
| Manresana de Micobacteriologia, SL | For profit | 2 | 2 | 1 | 2014 |
| National Center for Tuberculosis and Lung Diseases, Georgia | Government | 1 | 0 | 1 | 2017 |
| Stellenbosch University | Academic/Hospital | 1 | 1 | 1 | 2019 |
4 organizations
Page 1 / 1